Oncoustics AI: Funding, Investors & Team (Sep 2026)
Oncoustics is making and conveying progressed AI answers for minimal expense, harmless observation, diagnostics, and treatment checking of sicknesses with high neglected clinical need. Dissimilar to different players in the space, Oncoustics doesn't do picture acknowledgment. All things being equal, Oncoustics applies AI to crude ultrasound signals from promptly accessible handheld ultrasound gadgets to quickly separate sound versus sick tissues. There's an abundance of data in these crude signs and this approach uncovers novel biomarkers that can be lined up with existing norms and order frameworks. At first focusing on liver infection, a $30B worldwide indicative market, Oncoustics has recorded a Breakthrough Device Designation Request with the FDA for the OnX that identifies liver fibrosis and the 510K is in progress. A few follow-on liver items are being developed. Oncoustics likewise has clinical information on other organ signs including prostate, kidney, bosom and thyroid infections and malignant growths.
Oncoustics AI has raised $5.0M across 1 funding round on record, the most recent a Seed of $5.0M announced in Jul 2022.
That round is below the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Oncoustics AI Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Oncoustics AI Funding Rounds
Oncoustics AI Founders and Leadership Team
Contact details for the Oncoustics AI team: 1 of 1 has an email address on file.
Start 14-day free trial →Oncoustics AI Funding Compared to Other Artificial Intelligence Startups
Oncoustics AI's latest round of $5.0M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oncoustics AI in Artificial Intelligence and Toronto
Companies Similar to Oncoustics AI
Veeda AI is a physical artificial intelligence company dedicated to building the foundational spatial…
Fisent Technologies helps companies leverage the benefits of GenAI technology with its BizAI, an Applied…
Welcome to LoopX! We're here to enhance safety, productivity, and sustainability in mining and beyond through…
Wisr AI specializes in providing cyber risk intelligence and supply chain security solutions using AI-driven…
A publicly traded company that has built the ChatGPT of Quantum Computing and Supercomputing | CSE: QBTQ |…
Drive Hockey Analytics is making professional analytics available for amateur hockey. Its patent pending…
Laplace Robotics offers a compact all-in-one robot platform for lightweight singulation, sorting, and visual…
Tenet Fintech Group is an innovative Fintech service provider to the Chinese commercial lending sector.
Polysights is an AI-powered prediction market analytics and automation platform that delivers market…
shuriii is an edtech company that provides personalized platform based on artificial intelligence for…
Pricepoint develops an AI-powered revenue management platform for hotels and accommodation providers. Its…
Scispot is the best tech stack for biotech. It's the first-ever toolkit that lets you tailor it to your needs…
Oncoustics AI Funding FAQs
What does Oncoustics AI do?
Oncoustics is making and conveying progressed AI answers for minimal expense, harmless observation, diagnostics, and treatment checking of sicknesses with high neglected clinical need. Dissimilar to different players in the space, Oncoustics doesn't do picture acknowledgment. All things being equal, Oncoustics applies AI to crude ultrasound signals from promptly accessible handheld ultrasound gadgets to quickly separate sound versus sick tissues. There's an abundance of data in these crude signs and this approach uncovers novel biomarkers that can be lined up with existing norms and order frameworks. At first focusing on liver infection, a $30B worldwide indicative market, Oncoustics has recorded a Breakthrough Device Designation Request with the FDA for the OnX that identifies liver fibrosis and the 510K is in progress. A few follow-on liver items are being developed. Oncoustics likewise has clinical information on other organ signs including prostate, kidney, bosom and thyroid infections and malignant growths.
How much funding has Oncoustics AI raised?
Oncoustics AI has raised $5.0M across 1 round on record. The most recent is a Seed of $5.0M announced in Jul 2022.
When did Oncoustics AI last raise funding?
Oncoustics AI's most recent funding round on record is a Seed of $5.0M, announced in Jul 2022.
Who is the CEO of Oncoustics AI?
Beth Rogozinski is listed as CEO at Oncoustics AI.
Where is Oncoustics AI headquartered?
Oncoustics AI is based in Toronto, Ontario, Canada.
How many employees does Oncoustics AI have?
Oncoustics AI is in the 11-50 employee band.
How does Oncoustics AI's funding compare to other Artificial Intelligence startups?
Oncoustics AI's latest round of $5.0M is below the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Oncoustics AI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oncoustics AI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.